PR Hub

Helix BioPharma Corp.

Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts


AURORA, Ontario - Helix BioPharma Corp.
MORE..

Helix BioPharma Corp. Announces Fiscal 2009 Results


AURORA, Ontario - Helix BioPharma Corp.
MORE..

Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA


AURORA, Ontario - Helix BioPharma Corp.
MORE..

Helix BioPharma Closes Private Placement


AURORA, Ontario - Helix BioPharma Corp.
MORE..

Helix BioPharma Announces CDN$13.5 Million Private Placement


AURORA, Ontario - Helix BioPharma Corp.
MORE..
More News
Older News
S M T W T F S
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times